Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
01 2020
Historique:
received: 29 03 2019
revised: 13 09 2019
accepted: 15 10 2019
entrez: 27 12 2019
pubmed: 27 12 2019
medline: 1 7 2020
Statut: ppublish

Résumé

Creutzfeldt-Jakob disease (CJD) is a fatal disease presenting with rapidly progressive dementia, and most patients die within a year of clinical onset. CJD poses a potential risk of iatrogenic transmission, as it can incubate asymptomatically in humans for decades before becoming clinically apparent. In this Review, we sought evidence to understand the current iatrogenic risk of CJD to public health by examining global evidence on all forms of CJD, including clinical incidence and prevalence of subclinical disease. We found that although CJD, particularly iatrogenic CJD, is rare, the incidence of sporadic CJD is increasing. Incubation periods as long as 40 years have been observed, and all genotypes have now been shown to be susceptible to CJD. Clinicians and surveillance programmes should maintain awareness of CJD to mitigate future incidences of its transmission. Awareness is particularly relevant for sporadic CJD, which occurs in older people in whom clinical presentation could resemble rapidly developing dementia.

Identifiants

pubmed: 31876504
pii: S1473-3099(19)30615-2
doi: 10.1016/S1473-3099(19)30615-2
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2-e10

Subventions

Organisme : Department of Health
ID : 17/48/01
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Lesley Uttley (L)

School of Health and Related Research, University of Sheffield, Sheffield, UK. Electronic address: l.uttley@sheffield.ac.uk.

Christopher Carroll (C)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Ruth Wong (R)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

David A Hilton (DA)

Department of Neuropathology, University Hospitals Plymouth National Health Service Trust, Plymouth, UK.

Matt Stevenson (M)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH